lifestyle.marketresearchjournals.com

TRYNGOLZA® (olezarsen) approved in the European Union for familial chylomicronemia syndrome (FCS)

TRYNGOLZA® (olezarsen) approved in the European Union for familial chylomicronemia syndrome (FCS) – NEWSnet – News… as it used to be

More Press Releases

April 29, 2026

Appian Corporation to Host Investor Day on May 14, 2026

April 29, 2026

LB Pharmaceuticals Announces Publication in JAMA Psychiatry of Results from Phase 2 NOVA-1 Trial of LB-102 in Schizophrenia

April 29, 2026

Getty Images to Release First Quarter 2026 Financial Results on May 11, 2026

April 29, 2026

Flag Ship Acquisition Corp Receives Nasdaq Notification of Non-Compliance with Listing Rules